Literature DB >> 1333547

Angiotensin II stimulates endothelin-1 secretion in cultured rat mesangial cells.

M Kohno1, T Horio, M Ikeda, K Yokokawa, T Fukui, K Yasunari, N Kurihara, T Takeda.   

Abstract

The present study was designed to test two hypotheses: (1) that angiotensin II (Ang II) stimulates endothelin-1 secretion in cultured rat mesangial cells and (2) that atrial and brain natriuretic peptides (ANP and BNP) inhibit the above-mentioned secretion in these cells. Ang II stimulated immunoreactive (ir) endothelin-1 secretion in a concentration-dependent manner between 10(-8) M and 10(-7) M. The protein kinase C (PKC) inhibitors from two chemical classes, H7 and staurosporine, inhibited secretion following such stimulation. The stimulatory effect of Ang II was also abolished in the PKC-depleted cells. Rat ANP(1-28) and rat BNP-45, which are the respective major circulating forms of ANP and BNP in rats, potently inhibited Ang II-stimulated endothelin-1 secretion in a concentration-dependent manner. Inhibition by ANP and BNP of Ang II-stimulated endothelin-1 secretion was paralleled by an increase in the cellular level of cyclic guanosine 5'-monophosphate (GMP). The addition of a cyclic GMP analogue, 8-bromo cyclic GMP, reduced the stimulated endothelin-1 secretion. Rat ANP(5-25) was less effective that rat ANP(1-28) with respect to inhibiting ir-endothelin-1 secretion and increasing cellular cyclic GMP. These findings indicate that Ang II stimulates endothelin-1 secretion in cultured rat mesangial cells by a mechanism probably involving activation of PKC, and that rat ANP and BNP inhibit this stimulated secretion through a cyclic GMP-dependent process.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333547     DOI: 10.1038/ki.1992.361

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  20 in total

Review 1.  Physiology of endothelin and the kidney.

Authors:  Donald E Kohan; Edward W Inscho; Donald Wesson; David M Pollock
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

Review 2.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

3.  Activation of endothelin A receptors contributes to impaired responsiveness of renal mechanosensory nerves in congestive heart failure.

Authors:  Ulla C Kopp; Michael Z Cicha; Susan Y Jones
Journal:  Can J Physiol Pharmacol       Date:  2010-06       Impact factor: 2.273

4.  Crosstalk between the angiotensin and endothelin system in the cerebrovasculature after experimental induced subarachnoid hemorrhage.

Authors:  Stefan Wanderer; Jan Mrosek; Hartmut Vatter; Volker Seifert; Juergen Konczalla
Journal:  Neurosurg Rev       Date:  2017-07-29       Impact factor: 3.042

5.  Vasopressin regulates rat mesangial cell growth by inducing autocrine secretion of vascular endothelial growth factor.

Authors:  Atsuo Tahara; Junko Tsukada; Yuichi Tomura; Takeyuki Yatsu; Masayuki Shibasaki
Journal:  J Physiol Sci       Date:  2011-01-13       Impact factor: 2.781

6.  Endogenous cardiac vasoactive factors modulate endothelin production by cardiac fibroblasts in culture.

Authors:  K L King; J Winer; J P Mather
Journal:  Endocrine       Date:  1996-08       Impact factor: 3.633

Review 7.  Endothelin Receptor Antagonists: New Hope for Renal Protection?

Authors:  Sheldon Tobe; Donald E Kohan; Ranjit Singarayer
Journal:  Curr Hypertens Rep       Date:  2015-07       Impact factor: 5.369

8.  Differential effects of phosphoramidon on contractile responses to angiotensin II in rat blood vessels.

Authors:  L Chen; J R McNeill; T W Wilson; V Gopalakrishnan
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

9.  Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice.

Authors:  R J Fern; C M Yesko; B A Thornhill; H S Kim; O Smithies; R L Chevalier
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

10.  Regional haemodynamic effects of antagonists of angiotensin II, endothelin and adrenoceptors in conscious, vasopressin-deficient, genetically hypertensive rats.

Authors:  S M Gardiner; J E March; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.